Bellerophon Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2017-10-11: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2017-09-29; Total offering amount $23,437,050.
- 2017-05-19: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2017-05-09; Total offering amount $1,612,500.
- 2014-07-02: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2014-06-20; Total offering amount $1.
- 2014-02-21: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2014-02-10; Total offering amount $1.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2017-10-11 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2017-09-29 | $23,437,050 | $23,437,050 | $0 | 11 |
| 2017-05-19 | Rule 506(b) | OptionToAcquire | 2017-05-09 | $1,612,500 | $1,612,500 | $0 | 7 |
| 2014-07-02 | Rule 506(b) | OptionToAcquire | 2014-06-20 | $1 | $1 | $0 | 6 |
| 2014-02-21 | Rule 506(b) | OptionToAcquire | 2014-02-10 | $1 | $1 | $0 | 4 |